IRIS Accounts Production v25.3.0.601 14242084 Board of Directors 1.8.24 31.7.25 31.7.25 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh142420842024-07-31142420842025-07-31142420842024-08-012025-07-31142420842023-07-31142420842023-08-012024-07-31142420842024-07-3114242084ns15:EnglandWales2024-08-012025-07-3114242084ns14:PoundSterling2024-08-012025-07-3114242084ns10:Director12024-08-012025-07-3114242084ns10:PrivateLimitedCompanyLtd2024-08-012025-07-3114242084ns10:Micro-entities2024-08-012025-07-3114242084ns10:AuditExempt-NoAccountantsReport2024-08-012025-07-3114242084ns10:SmallCompaniesRegimeForAccounts2024-08-012025-07-3114242084ns10:FullAccounts2024-08-012025-07-3114242084ns5:CurrentFinancialInstruments2025-07-3114242084ns5:CurrentFinancialInstruments2024-07-3114242084ns10:RegisteredOffice2024-08-012025-07-31
REGISTERED NUMBER: 14242084 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 July 2025

for

Cryo Technologies Ltd

Cryo Technologies Ltd (Registered number: 14242084)






Contents of the Financial Statements
for the year ended 31 July 2025




Page

Balance Sheet 1


Cryo Technologies Ltd (Registered number: 14242084)

Balance Sheet
31 July 2025

2025 2024
£    £    £    £   
FIXED ASSETS 397 424

CURRENT ASSETS 12,752 32,793

CREDITORS
Amounts falling due within one year (12,175 ) (25,888 )
NET CURRENT ASSETS 577 6,905
TOTAL ASSETS LESS CURRENT
LIABILITIES

974

7,329

CAPITAL AND RESERVES 974 7,329

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Cryo Technologies Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 14242084

Registered office: 2 President Buildings
Saville Street Easte
Sheffield
South Yorkshire
S4 7UQ

Cryo Technologies Ltd (Registered number: 14242084)

Balance Sheet - continued
31 July 2025

NOTES TO THE FINANCIAL STATEMENTS

2. TRANSITION TO FRS 105

These financial statements are the first prepared in accordance with the FRS 105 micro-entities regime. In the prior year, the company prepared it's financial statements in accordance with FRS 102.

The transition has been applied retrospectively as required by section 28 of the the financial reporting standard applicable to micro-entities. The principal change arising from the adoption of FRS 105 is the derecognition of deferred tax balances which are not permitted under this standard.

The effect of this change on shareholders' funds at the date of transition was as follows:

Description £
Retained earnings 7,123
under FRS 102
as at 31 July 2024

Derecognition of +106
deferred tax liability

Retained earnings 7,229
under FRS 105 as at
1 August 2024

THe derecognition of the deferred tax liability reflects the requirement under FRS 105 that only current tax liability are recognised. No other adjustments were necessary on transition.

3. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2024 - 2 ) .



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Cryo Technologies Ltd (Registered number: 14242084)

Balance Sheet - continued
31 July 2025


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 29 October 2025 and were signed on its behalf by:





P Ferriday - Director